The 23-Valent Pneumococcal Polysaccharide Vaccine. Part I. Efficacy of PPV in the Elderly: A Comparison of Meta-Analyses

By Melegaro Alessia   Edmunds W. John  

European Journal of Epidemiology, Vol. 19, Iss. 4, 2004-04 ,pp. : 353-363

Springer Publishing Company

Access to resources Recommend Favorite

Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia

By Torling J.   Hedlund J.   Konradsen H.B.   Ortqvist A.  

Vaccine, Vol. 22, Iss. 1, 2003-12 ,pp. : 96-103

Elsevier

Access to resources Recommend Favorite

Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection

By Hoan-Jong L.   Jin-Han K.   Henrichsen J.   Konradsen H.B.   Seong-Hee J.   Hee-Young S.   Hyo-Seop A.   Yong C.   Hessel L.   Sung-Woo N.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1533-1538

Elsevier

Access to resources Recommend Favorite

Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults

By Feikin D.R.   Elie C.M.   Goetz M.B.   Lennox J.L.   Carlone G.M.   Romero-Steiner S.   Holder P.F.   O'Brien W.A.   Whitney C.G.   Butler J.C.   Breiman R.F.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 545-553

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users

By Amendola A.   Tanzi E.   Zappa A.   Colzani D.   Boschini A.   Musher D.M.   Zanetti A.R.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3720-3724

Elsevier

Access to resources Recommend Favorite